lymphoma Clinical Trials and Research
Also known as: non-hodgkin lymphoma, hodgkin lymphoma, nhl, hl, lymphatic cancer, lymphosarcoma, lymphoma cancer · ICD-10: C81-C86
Lymphoma is a type of cancer that begins in infection-fighting cells of the immune system called lymphocytes. Clinical trial research for lymphoma focuses on developing new therapies, improving existing treatments, and finding better ways to diagnose and monitor the disease. Find a Trial helps patients search for active studies.
Common questions about lymphoma clinical trials
What are clinical trials for lymphoma?
Clinical trials for lymphoma are research studies that test new ways to prevent, detect, or treat the disease. They aim to find out if new approaches are safe and effective, ultimately improving patient care. Data from ClinicalTrials.gov shows a wide range of studies.
Who can participate in lymphoma clinical trials?
Eligibility for lymphoma clinical trials varies based on the specific study. Factors often include the type and stage of lymphoma, previous treatments, age, and overall health. Each trial has specific criteria to ensure patient safety and study validity, as seen on ClinicalTrials.gov.
What are the different phases of lymphoma clinical trials?
Lymphoma clinical trials typically progress through phases: Phase 1 tests safety, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to standard ones. Phase 4 studies monitor long-term effects after approval. This structured approach is standard for medical research.
Do clinical trials for lymphoma cost money?
Generally, costs directly related to the experimental treatment or research procedures in a lymphoma clinical trial are covered by the study sponsor. Patients or their insurance may still be responsible for standard medical care costs, such as routine doctor visits or hospital stays.
What types of new treatments are being studied for lymphoma?
Current research for lymphoma, as indicated by NIH RePORTER and ClinicalTrials.gov, explores immunotherapies like CAR T-cell therapy, targeted therapies that block specific cancer pathways, and novel chemotherapy combinations. Researchers are also investigating new ways to reduce treatment side effects.
What common tests or procedures might be part of a lymphoma clinical trial?
Lymphoma clinical trials often involve regular blood tests, imaging scans (like PET or CT), and sometimes biopsies to monitor the disease and treatment response. Researchers also collect data on side effects and quality of life to assess the overall impact of new therapies.
Are there specific types of lymphoma that have more active research?
Both Hodgkin lymphoma and various subtypes of Non-Hodgkin lymphoma, such as diffuse large B-cell lymphoma and follicular lymphoma, are areas of active research. The focus often depends on prevalence, unmet needs, and scientific breakthroughs, as detailed on ClinicalTrials.gov.
What might prevent someone from joining a lymphoma clinical trial?
Common exclusion criteria for lymphoma clinical trials can include certain pre-existing medical conditions, prior treatments that might interfere with the study drug, or specific lab test results. These criteria help ensure patient safety and the integrity of the study data.
How to find a lymphoma trial that fits you
- Describe your lymphoma situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.